Geoffroyvan de Walle

Of Counsel

Brussels + 32.2.645.15.60

Connect:

Share

Geoffroy van de Walle's practice has focused on representing clients in antitrust investigations and litigation for more than 10 years. His representations span across Europe at the national and EU levels, as well as in emerging economies.

Geoffroy regularly assists clients with navigating cross-border merger control reviews, including complex investigations requiring divestitures. He also represents clients on all aspects of global cartels, abuse of dominance, and state aid investigations, including in appeal procedures before the courts.

Geoffroy also advises companies on ensuring antitrust compliance and has organized a number of compliance programs and on-site training sessions for clients. He also helps clients to ensure compliance with antitrust rules in relation to distribution, licensing, and other commercial agreements.

Prior to joining the Firm in 2015, Geoffroy was an antitrust associate at an international law firm in Brussels. He received his LL.M. from the New York University School of Law, where he was awarded the Frank T. Diersen prize for distinction in the LL.M. program and the Betty Bock prize for Competition Policy. Geoffroy regularly publishes articles and speaks on topics in the competition field.

Experience

  • Timken acquires Des-CaseJones Day advised The Timken Company in the acquisition of Des-Case Corp., a Nashville, Tenn.-based manufacturer of specialty filtration products for industrial lubricants.
  • Ubisoft signs deal for streaming Call of Duty and other Activision Blizzard gamesJones Day represented Ubisoft Entertainment SA (“Ubisoft”) on the corporate and antitrust aspects of its agreement with Activision Blizzard and Microsoft giving Ubisoft the cloud streaming rights for Call of Duty and all existing and current Activision Blizzard titles, as well as those to be released over the next 15 years once Microsoft’s acquisition of Activision Blizzard is completed.
  • Astellas acquires Iveric bioJones Day advised Astellas Pharma Inc. in the $5.9 billion cash acquisition of Iveric bio, Inc., a science-driven biopharmaceutical company focused on the discovery and development of novel treatments for retinal diseases with significant unmet medical needs.
  • Meridian Bioscience agrees to be acquired by SD Biosensor and SJL Partners in $1.53 billion all-cash transactionJones Day advised Meridian Bioscience, Inc. in its $1.53 billion all-cash acquisition by SD Biosensor and SJL Partners.
  • EssilorLuxottica and CooperCompanies form joint ventureJones Day advised EssilorLuxottica in the formation of its joint venture, SightGlass Vision, with CooperCompanies for the commercialization of novel spectacle lens technologies to expand the myopia management category.
  • EDF and Veolia create joint ventureJones Day acted as antitrust counsel to EDF in the formation of Waste2Glass, a 50/50 joint venture with Veolia that develops innovative radioactive waste treatment solutions based on Veolia's Geomelt® vitrification technology.
  • Eaton sells hydraulics business to DanfossJones Day advised Eaton Corporation as antitrust counsel in the sale of its hydraulics business to Danfoss Power Solutions for US$3.3 billion.
  • Cooper Tire & Rubber sold to The Goodyear Tire & Rubber Company for approximately $2.5 billion enterprise valueJones Day advised Cooper Tire & Rubber Company in its $2.5 billion sale to The Goodyear Tire & Rubber Company.
  • NVIDIA acquires Mellanox Technologies for approximately $7 billionJones Day advised NVIDIA Corporation in its acquisition of Mellanox Technologies, Ltd., an Israel-based leading supplier of end-to-end InfiniBand and Ethernet interconnect solutions and services for servers and storage.
  • Milliken & Company acquires Borchers from The Jordan CompanyJones Day advised Milliken & Company in its acquisition of Borchers Group Limited, a global specialty chemicals company known for its innovative high-performance coating additives and specialty catalyst solutions, from The Jordan Company, L.P.
  • NEP Group acquired by Carlyle Global PartnersJones Day advised the NEP Group, Inc., a Pittsburgh-based global leader in outsourced technical production for producers of live sports, entertainment, music and corporate events, in connection with the acquisition by Carlyle Global Partners of a majority stake in NEP Group.
  • Baker Hughes sells natural gas solutions business to First Reserve and Pietro FiorentiniJones Day advised Baker Hughes, a GE company (BHGE), in the sale of its global Natural Gas Solutions (NGS) business to two separate buyers, First Reserve and Pietro Fiorentini.
  • Global video game developer/publisher defends European Commission antitrust investigationJones Day is advising a global video game developer/publisher regarding a European Commission antitrust investigation into vertical restraints (including "geo-blocking" issues) in the video games sector.
  • Wabtec acquires Faiveley Transport for $1.8 billionJones Day advised Wabtec Corporation in the acquisition of Faiveley Transport S.A., a global supplier of high added value integrated systems for the railway industry, for a total of $1.8 billion in cash and stock, including assumed debt.
    • View All

    August 2023 Commentary

    ECJ Antitrust Ruling Not Likely to Jump-Start EC Deal Challenges in "Gap Cases"

    July 2023 Alert

    United Kingdom's CMA Reminds Businesses That Teamwork Must Stay on the Field

    March 2022 Commentary

    EU Chips Act: The EU's Push for Semiconductor Autonomy

    January 2022 Alert

    EU Court Annuls Landmark European Commission "Abuse of Dominance" Antitrust Decision

    June 2020 Alert

    EU Court Raises Bar for Commission to Block Certain Mergers

    December 2018 External Publications

    EU Merger Control and Harm to Innovation—A Long Walk to Freedom (from the Chains of Causation), Antitrust Bulletin, I-20

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.